NorthWest Biotherapeutics Inc (NWBO)

[RPD60]

HyGro,

You have made yourself clear that FDA will not be fooled by obvious trial manipulation etc that you claim occurred. But how do you square the fact that SNO gave Dr Liau a Plenary Lecture on this severely flawed trial at one of the most revered oncology conferences in the world? This would mean that no Oncologists who reviewed Dr Liaus abstract has any clue about the trial and all of its manipulations and, in effect, they are being duped.

Do you believe that?

Or is it possible that her peers see great promise in the trial results, however flawed, such that the trial is still worthy of a Plenary Lecture?

Final question—how does manipulating the trial and changing the endpoints and statistical plans etc enable people to live longer? Because if that is the secret then more trials should be run this way!